person

Janos Tamas V.

Country
Hungary
Department
Pulmonolgy Department

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 1 partner site.

Specializations

Chronic Obstructive Pulmonary Disease and Asthma

The investigator advances therapeutic strategies for Chronic Obstructive Pulmonary Disease and Asthma, emphasizing disease control and exacerbation reduction.

  • Bronchodilator optimization
  • Inhaled corticosteroid stewardship
  • Biologic agents for severe asthma

Clinical work integrates patient‑centered outcomes with longitudinal lung function assessment.

Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis

Focused investigation of Idiopathic Pulmonary Fibrosis and related Interstitial Lung Diseases drives innovation in antifibrotic therapy.

  • Antifibrotic drug evaluation
  • High‑resolution imaging biomarkers
  • Combination regimens with immunomodulators

Efforts target slowing disease progression and improving quality of life.

Pulmonary Hypertension and Right Heart Failure

The investigator addresses therapeutic gaps in Pulmonary Arterial Hypertension and associated right ventricular dysfunction.

  • Targeted vasodilator pathways
  • Risk stratification using hemodynamic metrics
  • Adjunctive treatment for right heart failure

Research aligns hemodynamic improvement with functional capacity outcomes.

Bronchiectasis and Chronic Respiratory Infections

Clinical programs concentrate on management of Bronchiectasis and recurrent respiratory infections in vulnerable populations.

  • Long‑term antibiotic stewardship
  • Airway clearance techniques
  • Microbiome‑directed therapeutics

Goals include reducing exacerbation frequency and preserving lung architecture.

Respiratory Manifestations of Systemic and Rare Diseases

Investigation extends to pulmonary involvement in systemic conditions such as systemic lupus erythematosus, amyloidosis, and rare neuromuscular disorders.

  • Immune‑mediated lung injury
  • Therapies for amyloid‑related pulmonary disease
  • Ventilatory support in neuromuscular weakness

Approaches integrate multidisciplinary care to mitigate multisystem impact.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.